This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

16 Sep 2019

New Iron API – Iron(III) Polymaltose Complex

Dr. Paul Lohmann® has recently developed Iron(III) Polymaltose Complex as an active pharmaceutical ingredient. This product is available including API documentation (DMF/ASMF) for the registration of a medicinal drug at health authorities.

Iron(III) Polymaltose Complex is mainly used to treat iron deficiency anemia. Moreover, there are studies indicating the application as a phosphate binder to treat hyperphosphatemia.

Iron(III) Polymaltose Complex is known for its high bioavailability as well as for its high patient compliance due to less side effects related to the upper gastro intestinal tract.

For further information meet Dr. Paul Lohmann® in Hall 4.2/Stand 42D14.

Mentioned Companies
Dr. Paul Lohmann GmbH & Co. KGaA
View company profile